Back to the main directory
EarningsReview / Equity
- 4Q25 Model Update: Maintain O/P & Lower TP to $6,000 by BNP Paribas
- Guidance slightly above expectations, pipeline resilient by BNP Paribas
- CAGNY Takeaways: Near-Term Still Subdued, But Optimistic on Ability to Drive Toward Algorithm Long-Term by BNP Paribas
- Challenging times, as expected: first take by BNP Paribas
- Softer trends in the ST but Belgium can bring positive news by BNP Paribas
- Thoughts From The Road by BNP Paribas
- Glyphosate settlement by BNP Paribas
- Corticeira - 4Q25: Operating weakness but strong FCF generation by JB Capital Markets
- DFDS - Clouded horizon by Danske Bank Equity Research
- Zealand Pharma - Waiting for petrelintide phase 2 relief by Danske Bank Equity Research
- Recordati - ISTURISA® DRIVING GROWTH, PENDING MORE M&A DEALS by Equita Sim
- FY25 results: modest Q4 LFL beat by BNP Paribas
- FY’25: slightly better all around by BNP Paribas
- FY 2025: good print, all eyes on 2026 guidance by BNP Paribas
- 2H25 first take - H2 beat, seeing unit cost inflation into 2026 by BNP Paribas
- Broadpeak - Dynamique de croissance soutenue by MidCap Partners
- European CSD Data (Nielsen, Jan’26): Better industry vols in January, supported by calendar shift by BNP Paribas
- Read Across from Pool Corp call by BNP Paribas
- European Beer Data (Nielsen, Jan’26): Guinness surges to +21% by BNP Paribas
- FY25 results: conf call: Q1 IMF impact, but.. by BNP Paribas
- Bourse Direct - Better-than-expected results by MidCap Partners
- Non material data changes by BNP Paribas
- Solid call with group flagging extraordinary demand for Advansys by BNP Paribas
- H2 2025 CC feedback by BNP Paribas
- Eyes on growth by BNP Paribas